Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;32(6):3358-3362.
doi: 10.1177/11206721221078649. Epub 2022 Feb 7.

Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®)

Petroni Sergio  1 , Iarossi Giancarlo  1 , Federici Matteo  1 , De Sanctis Carlo Maria  1 , Petrocelli Gianni  1 , Rosa Parrilla  1 , Paola Valente  1 , Buzzonetti Luca  1
Affiliations

Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®)

Petroni Sergio et al. Eur J Ophthalmol. 2022 Nov.

Abstract

Purpose: The aim of this study was to evaluate in vivo the tear film in infantile nephropathic cystinosis patients with corneal crystals treated with topical viscous cysteamine hydrochloride (Cystadrops®).

Methods: Ten eyes of five patients with nephropathic cystinosis aged from 10 to 35 years were included in this study. The patients were under treatment with viscous cysteamine hydrochloride formulation containing 3.8 mg/mL cysteamine (vCH 0.55%, equivalent to 0.55% CH; Cystadrops®; Recordati rare Diseases, Puteaux, France) to reduce corneal crystal density. Five age and sex matched individuals were randomly selected as control group. Tear osmolarity testing (TearLabTM) was performed to assess the in vivo osmolarity of patients under treatment and compared to control group values. Tear film break-up time (TBUT) and basic tear secretion (Schirmer test) were also assessed.

Results: Mean tear osmolarity was 294.8 mOsms/L (±10.4), with a mean absolute difference of 1.85 mOsms/L (±2.13) between the eyes. There was no statistically significant difference between the osmolarity readings of cystinosis and the control group (294.8 ± 10.4 vs 299.4 ± 6.2mOsm/L, respectively; p = 0.39). The mean TBUT was 10.2 ± 0.83 s in the study group versus 10 ± 0.7 s in controls (p = 0.62). The mean Schirmer test score was 9.2 ± 0.83 mm in the patients versus 10.2 ± 0.83 mm in the controls (p = 0.14).

Conclusions: The TearLabTM osmolarity system test showed good reliability and precision in repeated measurements. This is the first report using the TearLab osmolarity system to assess tear film in patients with cystinosis treated with vCH 0.55%. TearLabTM examination showed that the use of vCH 0.55% drops does not determine alterations of the tear film quality.

Keywords: corneal crystal; ocular cystinosis; tear osmolarity.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Gahl WA, Bashan N, Tietze Fet al. et al. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 1982; 217: 1263–1265. - PubMed
    1. Kaiser-Kupfer MI, Caruso RC, Minkler DSet al. et al. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 1986; 104: 706–711. - PubMed
    1. Tsilou ET, Rubin BI, Reed GFet al. et al. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. Cornea 2002; 21: 173–176. - PubMed
    1. Kocabora MS, Ozbilen KT, Altunsoy Met al. et al. Clinicopathological features of ocular cystinosis. Clin Exp Ophthalmol 2008; 36: 778–781. - PubMed
    1. Bishop R. Ocular complications of infantile nephropathic cystinosis. J Pediatr 2017; 183S: S19–S21. - PubMed

LinkOut - more resources